MedTrace Logo

Screening for Early Lung Cancer in Shanghai, China

NCT02185495 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 3000

Last updated 2014-12-18

No results posted yet for this study

Summary

Imaging procedures including chest X-ray and low-dose computed tomography may be effective in lung cancer early detection. Yet it is unknown whether low-dose computed tomography combined with computer aided detection （CAD) is more effective than LDCT in screening of early lung cancer.

Conditions

Interventions

BEHAVIORAL

Observer nodule detection

Radiologists will detect the nodules.

DEVICE

Computer-aided nodule detection

Computed-aided detection (CAD) software will be used to detect the nodules.

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    collaborator OTHER

  • Shanghai Pulmonary Hospital, Shanghai, China

    collaborator OTHER

  • Fudan University

    collaborator OTHER

  • Ruijin Hospital

    collaborator OTHER

  • Shanghai Public Health Clinical Center

    collaborator OTHER_GOV

  • Shanghai Changzheng Hospital

    lead OTHER

Principal Investigators

  • Shiyuan Liu, MD · Radiology Department of Shanghai Changzheng Hospital

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2017-09-30
Completion
2017-09-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02185495 on ClinicalTrials.gov